Wednesday, July 8, 2026

Drug profile · INN

alatrofloxacin mesylate

alatrofloxacin mesylate (TROVAN PRESERVATIVE FREE) is a bacterial dna gyrase inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — alatrofloxacin mesylate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

alatrofloxacin mesylate (TROVAN PRESERVATIVE FREE) is a bacterial dna gyrase inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN alatrofloxacin mesylate
Brand TROVAN PRESERVATIVE FREE
Mechanism Bacterial DNA gyrase inhibitor
Target Bacterial DNA gyrase
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Bacterial DNA gyrase inhibitor

Primary target: Bacterial DNA gyrase

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. cinoxacin Bacterial DNA gyrase inhibitor
  2. ciprofloxacin Bacterial DNA gyrase inhibitor
  3. ciprofloxacin hydrochloride Bacterial DNA gyrase inhibitor
  4. moxifloxacin hydrochloride Bacterial DNA gyrase inhibitor
  5. ofloxacin Bacterial DNA gyrase inhibitor
  6. besifloxacin hydrochloride Bacterial DNA gyrase inhibitor

Frequently asked questions

What is alatrofloxacin mesylate?

alatrofloxacin mesylate (TROVAN PRESERVATIVE FREE) is a bacterial dna gyrase inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for alatrofloxacin mesylate?

TROVAN PRESERVATIVE FREE is a marketed brand name for alatrofloxacin mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of alatrofloxacin mesylate?

alatrofloxacin mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.